ONCOLOGÍA PEDIÁTRICA

Foto de ONCOLOGÍA PEDIÁTRICA

Foto de KU Leuven

KU Leuven

Lovaina, Bélgica

Publications en collaboration avec des chercheurs de KU Leuven (6)

2024

The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis
Pediatric Blood and Cancer

2021

Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis
Critical Reviews in Oncology/Hematology, Vol. 161

2017

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
Journal of Pediatrics, Vol. 189, pp. 72-78.e3

2016

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
RMD Open, Vol. 2, Núm. 1
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics
Nature Communications, Vol. 7

2013

Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years
Pediatric Blood and Cancer, Vol. 60, Núm. 2, pp. 175-184